HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Compliance with taking imatinib mesylate in patients with chronic myeloid leukemia in the chronic phase.

AuthorsToru Kiguchi, Tetsuzo Tauchi, Yoshikazu Ito, Keisuke Miyazawa, Yukihiko Kimura, Kazuma Ohyashiki
JournalLeukemia research (Leuk Res) Vol. 33 Issue 3 Pg. 506-8 (Mar 2009) ISSN: 1873-5835 [Electronic] England
PMID18533259 (Publication Type: Letter)
Chemical References
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
Topics
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy)
  • Leukemia, Myeloid, Chronic-Phase (drug therapy)
  • Patient Compliance (statistics & numerical data)
  • Piperazines (therapeutic use)
  • Pyrimidines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: